AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8550130
Drug: Nitroxazepine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroxazepine (25 mg PO, HS)
Trial: 1960313
Drug: Intravenous ribose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ribose (3.3 mg/kg per min)
Trial: 6173512
Drug: Individual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual treatment (traditional, stimulus-response type treatment of specific language deficits)
Trial: 6173512
Drug: Group therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group therapy (designed to improve communication through group interaction and discussion, no direct treatment of specific language deficits)
Trial: 15678736
Drug: Propofol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (30 mg kg(‐1)h(‐1)) + Fentanyl (2 microg kg(‐1))
Trial: 15678736
Drug: Propofol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (30 mg kg(‐1)h(‐1)) + Normal Saline
Trial: 9845405
Drug: Ranitidine 75
RxNorm normalized name: ranitidine 75 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 75 mg (effervescent)
Trial: 9845405
Drug: Ranitidine 75
RxNorm normalized name: ranitidine 75 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 75 mg (tablet)
Trial: 9845405
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg (effervescent)
Trial: 9845405
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg (tablet)
Trial: 9845405
Drug: Ranitidine 75
RxNorm normalized name: ranitidine 75 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 75 mg (tablet) vs Cimetidine 200 mg (tablet)
Trial: 2569435
Drug: Sulphasalazine at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulphasalazine at 1.5 g and 3.0 g
Trial: 28243685
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 10 mg dimemorfan phosphate tablets
Trial: 28243685
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 20 mg dimemorfan phosphate tablets under fed conditions
Trial: 28243685
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 40 mg dimemorfan phosphate tablets
Trial: 28243685
Drug: Multiple-dosing of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dosing of 20 mg dimemorfan phosphate tablets 3 times per day
Trial: 28243685
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 20 mg dimemorfan phosphate tablets under fasting conditions
Trial: 25512675
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol (CZP) 400 mg every 2 weeks at weeks 0-4; CZP 200 mg every 2 weeks at weeks 6-16
Trial: 25512675
Drug: Placebo→CZP (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo→CZP (placebo at weeks 0-2; CZP loading dose at weeks 2-6; CZP 200 mg every 2 weeks at weeks 8-16)
Trial: 24259595
Drug: Medication Monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medication Monitoring and Optimization (MeMO) program
Trial: 18053580
Drug: Light room
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light room therapy
Trial: 2576667
Drug: Atenolol, 50
RxNorm normalized name: Atenolol, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol, 50 mg/day (Control)
Trial: 2576667
Drug: Indenolol, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indenolol, 60 mg/day
Trial: 1269217
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg dextroamphetamine
Trial: 1269217
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg dextroamphetamine
Trial: 1269217
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg dextroamphetamine
Trial: 15968233
Drug: Once-daily atomoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily atomoxetine
Trial: 9849290
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for laryngospasm
Trial: 2511023
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin (Group A, n = 11)
Trial: 1233383
Drug: Chlorpromazine-imipramine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine-imipramine combination
Trial: 30703444
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 100 mg moguisteine
Trial: 30703444
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 200 mg moguisteine
Trial: 30703444
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 400 mg moguisteine
Trial: 30703444
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of 200 mg moguisteine (three times daily for five consecutive days)
Trial: 19373517
Drug: Community care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community care participants received cessation pamphlets and information on local treatment programs
Trial: 15546073
Drug: Micafungin 50
RxNorm normalized name: micafungin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin 50 mg (1 mg/kg for patients weighing <50 kg)
Trial: 15546073
Drug: Fluconazole 400
RxNorm normalized name: fluconazole 400 MG in 200 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 400 mg (8 mg/kg for patients weighing <50 kg)
Trial: 11444499
Drug: Nicorandil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (0.1 mg/kg) administered during cardiopulmonary bypass
Trial: 7997395
Drug: Digoxin tablets
RxNorm normalized name: Digoxin Tablets
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin tablets
Trial: 7997395
Drug: Digoxin capsules
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin capsules
Trial: 7997395
Drug: Control (tablets)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (tablets)
Trial: 7997395
Drug: Control (capsules)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (capsules)
Trial: 26764884
Drug: Sofosbuvir therapy
RxNorm normalized name: Sofosbuvir
DrugBank: Sofosbuvir (DB08934)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sofosbuvir therapy with peginterferon and ribavirin
Trial: 23252003
Drug: HTESB therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTESB therapy
Trial: 17183628
Drug: Potent antiretroviral
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potent antiretroviral therapy (ART)
Trial: 14504915
Drug: 7.5 mg/week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg/week of methotrexate
Trial: 14504915
Drug: 2 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g/day of sulphasalazine
Trial: 30453379
Drug: 22 G
RxNorm normalized name: Empty Carpuject 2 mL 22 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22 G needle
Trial: 26407017
Drug: 25 G
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 G needle
Trial: 3986068
Drug: Extradural analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural analgesia (local anaesthetics from before skin incision until 24 h after skin incision plus extradural morphine 4 mg every 12 h from 3 h to 72 h after skin incision)
Trial: 3986068
Drug: General anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthesia with low‐dose fentanyl plus intermittent systemic morphine for postoperative pain
Trial: 31295161
Drug: Prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 2 mg q.d. for 4 weeks
Trial: 30328976
Drug: Infusion pump
RxNorm normalized name: Infusion Pump 50cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion pump A at 100 mL/h
Trial: 30328976
Drug: Infusion pump
RxNorm normalized name: Infusion Pump 50cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion pump A at 300 mL/h
Trial: 30328976
Drug: Infusion pump
RxNorm normalized name: Infusion Pump 50cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion pump B at 100 mL/h
Trial: 30328976
Drug: Infusion pump
RxNorm normalized name: Infusion Pump 50cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion pump B at 300 mL/h
Trial: 15601806
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of rHA
Trial: 15601806
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of HSA
Trial: 7794983
Drug: Community-based arthritis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based arthritis education program (6 weekly sessions of 2.5 hours' duration)
Trial: 9668369
Drug: GM1 ganglioside
RxNorm normalized name: Porcine GM1 ganglioside
DrugBank: Ganglioside GM1 (DB16948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM1 ganglioside treatment
Trial: 376054
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg daily for six weeks
Trial: 376054
Drug: Carbenoxolone sodium
RxNorm normalized name: carbenoxolone sodium
DrugBank: Carbenoxolone (DB02329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenoxolone sodium 300 mg daily for one week then 150 mg daily for five weeks
Trial: 31112957
Drug: Levofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (500 mg per day for 4 weeks)
Trial: 31112957
Drug: Levofloxacin and
RxNorm normalized name: levofloxacin and ornidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin and azithromycin combination
Trial: 28068121
Drug: Culturally adapted
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally adapted Motivational Enhancement Therapy delivered in Spanish
Trial: 25807939
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg daily dose of delayed-release prednisone
Trial: 24516413
Drug: Actovegin (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actovegin (2,000 mg/day for up to 20 intravenous infusions followed by 1,200 mg/day orally)
Trial: 18037817
Drug: Duloxetine (40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (40, 60, 80, 120 mg/day)
Trial: 18037817
Drug: SSRIs (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRIs (10 mg/day escitalopram, 20 mg/day fluoxetine and paroxetine)
Trial: 15239013
Drug: Titanium implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titanium implant (Bak‐C; Spine‐Tech, Minneapolis)
Trial: 10958599
Drug: Amifostine (910
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (910 mg/m2) given as a short infusion prior to cisplatin
Trial: 15036788
Drug: Omeprazole (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (80 mg)
Trial: 28157653
Drug: Suppository +
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppository + vaginal cream + oral vitamin B complex (group C)
Trial: 28157653
Drug: Suppository +
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppository + oral antifungal agents (group A)
Trial: 28157653
Drug: Suppository +
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppository + vaginal cream (group B)
Trial: 26446482
Drug: High-dose soy
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose soy (HDS) - 2 soy muffins containing 25 g soy protein
Trial: 26446482
Drug: Low-dose soy
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose soy (LDS) - 1 soy and 1 wheat muffin containing 12.5 g soy protein and 12.5 g whey protein
Trial: 26446482
Drug: Control -
RxNorm normalized name: HISTAMINE 6 mg in 1 mL PERCUTANEOUS INJECTION [Positive Skin Test Control - Histamine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control - 2 wheat muffins containing 25 g whey protein
Trial: 21670457
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of depot hydroxyprogesterone 500 mg 5 to 14 days before surgery
Trial: 17098421
Drug: pviFOX (oxaliplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pviFOX (oxaliplatin plus protracted infusion of 5‐fluorouracil)
Trial: 11294041
Drug: Mianserin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin (30 mg/day)
Trial: 9447285
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (LH‐RH agonist: LHRH‐A)
Trial: 29689636
Drug: HIFU started
RxNorm normalized name: venetoclax
DrugBank: Venetoclax (DB11581)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: HIFU started 1 minute after SonoVue injection
Trial: 29689636
Drug: HIFU started
RxNorm normalized name: venetoclax
DrugBank: Venetoclax (DB11581)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: HIFU started 10 minutes after SonoVue injection
Trial: 27704865
Drug: Local thermal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local thermal therapy for 2 weeks
Trial: 27704865
Drug: Local thermal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local thermal therapy
Trial: 21711204
Drug: 1600 mg
RxNorm normalized name: glycerin 1600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg Avena sativa herb extract
Trial: 21711204
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg Avena sativa herb extract
Trial: 21711204
Drug: 2400 mg
RxNorm normalized name: pancreatin 2400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2400 mg Avena sativa herb extract
Trial: 15558393
Drug: 9-month, twice-weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9-month, twice-weekly exercise program (n = 11)
Trial: 9236555
Drug: Intramuscular immune
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular immune serum globulin (4 mL of 16% polyvalent immune serum globulin every 2 months, n = 450)
Trial: 8353585
Drug: Arterial line
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arterial line sample with discard volume deadspace + 2 mL
Trial: 8353585
Drug: Arterial line
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arterial line sample with discard volume deadspace + 4 mL
Trial: 31965072
Drug: Liraglutide (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (1.8 mg/d)
Trial: 9458325
Drug: PALA (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PALA (250 mg/m² on day 1) + FA (20 mg/m²) + 5-FU (400 mg/m², 5 min i.v. bolus injection) on days 2-5
Trial: 9458325
Drug: 5-FU (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (400 mg/m², 5 min i.v. bolus injection) + FA (20 mg/m²) on days 2-5 without PALA
Trial: 2229705
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (education and psychological support in addition to routine care)
Trial: 11774104
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg/d for 8 weeks
Trial: 30485325
Drug: Dengue immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dengue immunoglobulin G titres in children with prior medical diagnosis of dengue infection
Trial: 30485325
Drug: Dengue immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dengue immunoglobulin G titres in children without prior medical diagnosis of dengue infection
Trial: 30485325
Drug: Dengue immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dengue immunoglobulin G levels above the median value
Trial: 27919284
Drug: ML Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ML Flow test positivity
Trial: 24747100
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy episodes for life-threatening VA
Trial: 24747100
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy episodes for life-threatening VA in patients not on beta-blocker therapy
Trial: 20518617
Drug: Perindopril/indapamide fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril/indapamide fixed-dose combination
Trial: 15985013
Drug: Cycled IL-2
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cycled IL-2 plus antiretroviral therapy (ART)
Trial: 10646049
Drug: Racecadotril (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racecadotril (1.5 mg/kg three times daily)
Trial: 10646049
Drug: Loperamide (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (0.03 mg/kg three times daily)
Trial: 1804731
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (including antispasmodic Colpermin)
Trial: 6683632
Drug: Adriamycin-cyclophosphamide (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adriamycin-cyclophosphamide (6 courses) + Levamisole (immunotherapy for 2 years)
Trial: 27456494
Drug: Prebiotics (oligofructose-enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotics (oligofructose-enriched inulin 8 g orally/day)
Trial: 27456494
Drug: Placebo (maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrin 3.3 g orally/day)
Trial: 20963579
Drug: Transcranial Magnetic
RxNorm normalized name: transcranial magnetic stimulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Magnetic Stimulation (TMS) over left ventral premotor cortex (L-PMv)
Trial: 20963579
Drug: Transcranial Magnetic
RxNorm normalized name: transcranial magnetic stimulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Magnetic Stimulation (TMS) over left dorsal premotor cortex (L-PMd)
Trial: 17331650
Drug: Betadine ointment
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betadine ointment gauzes (Group B)
Trial: 17331650
Drug: Betadine ointment
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betadine ointment gauzes (Group D)
Trial: 16279563
Drug: Food elimination
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food elimination diet based on skin prick and atopy patch testing results
Trial: 8497364
Drug: 0.75% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% metronidazole vaginal gel
Trial: 475943
Drug: Bupropion 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion 50 mg
Trial: 475943
Drug: Amitriptyline 25
RxNorm normalized name: amitriptyline 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 25 mg (base)
Trial: 475943
Drug: Dexamphetamine 5
RxNorm normalized name: Dexamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamphetamine 5 mg
Trial: 31094803
Drug: 8-mg dexamethasone
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-mg dexamethasone
Trial: 22574814
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (n=19)
Trial: 19713257
Drug: Gabapentin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (3 x 400 mg)
Trial: 19713257
Drug: Phenytoin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (3 x 100 mg)
Trial: 12394224
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate (RBC) 400 mg B.I.D., clarithromycin (C) 500 mg B.I.D., metronidazole (M) 500 mg every morning and 1,000 mg every evening for 14 days
Trial: 12394224
Drug: Previous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previous treatment with omeprazole (O) 20 mg, clarithromycin (C) 250 mg, metronidazole (M) 500 mg
Trial: 12394224
Drug: Previous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previous treatment with ranitidine bismuth citrate (RBC) 400 mg, tetracycline (T) 1,000 mg, metronidazole (M) 500 mg